Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Biocentrum i Varberg AB
AB
Dissolved
Org 5567015739
Motion picture projection activities · NACE 5914
Est. 2006
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2018
SEK 2,7M
+1% vs 2017
EBITDA margin
69.1%
+2% vs 2017
Equity ratio
2.2%
Financial strength
Net profit 2018
SEK 274K
-69% vs 2017
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
2M
2016
2M
0%
2017
2M
0%
2018
Key figures
Annual report 2018
Revenue
SEK 2,7M
+1%
EBITDA
SEK 1,9M
+2%
Net profit
SEK 274K
-69%
Total assets
SEK 20,7M
-4%
Equity
SEK 464K
-61%
Employees
0
—
Company information
Legal name
Biocentrum i Varberg AB
Org number
5567015739
Legal form
Aktiebolag
NACE code
5914 · Motion picture projection activities
Founded
6 april 2006
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Company purpose
Bolaget skall äga och förvalta fast egendom och bedriva biografverksamhet samt därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Motion picture projection activities
Companies in
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2016
3M
2017
3M
2018
EBITDA
SEK millions
0M
1M
1M
2M
2M
2M
2016
2M
2017
2M
2018
Income statement
SEK thousands
Item
2016
2017
2018
Revenue
2 626
2 688
2 705
Staff expenses
—
—
—
EBITDA
2 034
1 831
1 868
Depreciation & amort.
−417
−379
−379
EBIT
1 617
1 452
1 489
Net financials
−871
−358
−989
Profit before tax
337
959
406
Tax
−117
−89
−132
Net profit
220
870
274
Balance sheet
SEK thousands
Item
2016
2017
2018
Total assets
22 099
21 501
20 747
Equity
321
1 190
464
Long-term debt
17 737
16 737
18 700
Short-term debt
3 783
3 421
1 511
Total debt
21 520
20 158
20 211
Financial ratios
5-year trend
EBITDA margin
69.1%
This company
15.8%
Market median
+337% vs market
2016
2018
Equity ratio
2.2%
This company
38.2%
Market median
-94% vs market
2016
2018
Return on equity
59.1%
This company
18.4%
Market median
+221% vs market
2016
2018
Net profit margin
10.1%
This company
8.1%
Market median
+25% vs market
2016
2018
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
2016
2018
Debt / equity
43.71×
This company
0.62×
Market median
-6950% vs market
2016
2018
Annual reports & filings
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PR
Per Richard Kjellander
Audit
Audit
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KP
Karl Peter Fornstam
Board of Directors
2020
DS
Daphne Suzanna Holmqvist
Deputy Board Member
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Biocentrum i Varberg AB also hold positions in
0
other companies.
Person
Role here
Other companies
Per Richard Kjellander
Audit
0 companies
Karl Peter Fornstam
Board of Directors
0 companies
Daphne Suzanna Holmqvist
Deputy Board Member
0 companies